This Study Aims to Compare Asthma Control in Children Monitored With FeNO Against a Historical Cohort Without FeNO. Secondary Objectives Include Evaluating Associations Between FeNO Levels, ACT/C-ACT Scores, Eosinophil Counts, FEV1%, ICS Adherence, and Exacerbation Frequency.
Recruiting · NCT07788534 · Interventional (participants receive a specific treatment) · Lead sponsor: King Faisal Specialist Hospital & Research Center
View the official record on ClinicalTrials.gov →Interventions studied
FENOPFT
What this trial is about
This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO
Who can take part
Age range
6 Years to 14 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Children aged 6 to 14 years with a physician-diagnosed asthma.
- Minimum of three months' follow-up at the pediatric respiratory clinic.
- Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data
Exclusion criteria
- Presence of other chronic pulmonary diseases (e.g., cystic fibrosis).
- Recent respiratory infections within four weeks prior to enrollment.
- Current treatment with biologic agents affecting asthma inflammation.
Where it is running
2 locations listed.
- King Faisal Sepiclaized Hospital and Research Center - Jeddah, Mecca Region, Saudi Arabia
- king Faisal specialized hospital and research center - Jeddah, Western Region, Saudi Arabia